Anthony T. Podany

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

Rajesh T. Gandhi, Joshua C. Cyktor, Ronald J. Bosch et al. · The Journal of Infectious Diseases · 2020 · 142 citations · Full text

Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide

Anthony T. Podany, Sara H Bares, Joshua P Havens et al. · AIDS · 2018 · 83 citations

Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

Anthony T. Podany, Yajing Bao, Susan Swindells et al. · Clinical Infectious Diseases · 2015 · 73 citations · Full text

High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial

Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova et al. · Contemporary Clinical Trials · 2020 · 55 citations · Full text

Pulmonary Tuberculosis, High-dose Rifapentine, Medicine +5

Adipocytes impair efficacy of antiretroviral therapy

Jacob Couturier, Lee C. Winchester, James Suliburk et al. · Antiviral Research · 2018 · 47 citations · Full text

Obesity, Metabolic Syndrome, Inflammation +6